Jesús
San Miguel Izquierdo
Consultor Investigador
University Hospitals Birmingham NHS Foundation Trust
Birmingham, Reino UnidoUniversity Hospitals Birmingham NHS Foundation Trust-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2018
-
Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma
New England Journal of Medicine, Vol. 378, Núm. 6, pp. 518-528